Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives

Journal Title: Turkish Journal of Hematology - Year 2019, Vol 36, Issue 1

Abstract

.

Authors and Affiliations

Won Sriwijitalai, Viroj Wiwanitkit

Keywords

Related Articles

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies

Invasive fungal infections caused by drug-resistant organisms are an emerging threat to heavily immunosuppressed patients with hematological malignancies. Modern early antifungal treatment strategies, such as prophylaxis...

Plasma Ischemia-Modified Albumin Levels and Dynamic Thiol/ Disulfide Balance in Sickle Cell Disease: A Case-Control Study

Objective: Sickle cell disease (SCD), described as a group of inherited blood disorders, affects millions of people throughout the world and is particularly common in the southern part of Turkey. We aimed to determine th...

Download PDF file
  • EP ID EP548205
  • DOI 10.4274/tjh.galenos.2018.2018.0397
  • Views 107
  • Downloads 0

How To Cite

Won Sriwijitalai, Viroj Wiwanitkit (2019). Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives. Turkish Journal of Hematology, 36(1), 53-54. https://www.europub.co.uk/articles/-A-548205